Insurance coverage · 2026 formulary
Does Aetna cover Zepbound in 2026?
Short answer: yes on most commercial Aetna plans, but with a stricter path than UnitedHealthcare. Zepbound sits on the CVS Caremark formulary Aetna uses as a Tier 3 weight-management drug — prior authorization required, plus step therapy on most plans (you have to try Wegovy first or document an intolerance).
The step-therapy requirement (the actual gate)
The PA criteria for Zepbound at Aetna are similar to other payers. The differentiator is step therapy: most 2026 Aetna commercial plans require you to have tried Wegovy for 4-6 months without meaningful weight loss (typically defined as ≥5% body weight) OR documented a specific intolerance or contraindication, BEFORE Aetna will cover Zepbound.
The clinical logic is cost — Wegovy has a lower net price to Aetna than Zepbound currently, so semaglutide-first is Aetna's preferred cost-management path. The patient experience: if you have never taken Wegovy, expect a step-therapy denial on first submission unless your prescriber writes a strong exception request.
Full PA criteria
- BMI documentation: ≥30 alone, or ≥27 with a weight-related comorbidity (T2D, hypertension, dyslipidemia, OSA, CVD).
- 6-month lifestyle-intervention attempt: Aetna enforces this more consistently than UHC or Cigna. Chart notes from your PCP documenting diet + exercise + weight measurements over 6 months.
- Step therapy: prior Wegovy trial (4-6 months minimum) with insufficient response, OR documented intolerance/contraindication to semaglutide.
- Contraindication attestation: no personal or family history of medullary thyroid carcinoma or MEN 2.
Cost with Aetna
| Path | Monthly out-of-pocket | Notes |
|---|---|---|
| Aetna + PA + savings card | $25 | Lilly Zepbound Savings Card, up to 13 fills |
| Aetna + PA approved, no savings card | $30-90 | Standard Tier 3 copay |
| Step therapy denied, cash via LillyDirect | $349-499 | LillyDirect Zepbound self-pay tiers |
| Aetna list-price fallback | $1,059 | Almost no one pays this |
If Aetna denied you
- 1. Identify the specific criterion. Denial letter must state which PA element failed. Step-therapy denials are the most common; re-submission with Wegovy trial documentation resolves most.
- 2. Submit a step-therapy exception if warranted. Prescriber attests that Wegovy is medically inappropriate (allergy, contraindication, prior serious adverse event). Aetna must respond within 72 hours standard, 24 hours urgent.
- 3. Request peer-to-peer review. Prescriber calls an Aetna medical director. Approval rate is much higher than paper submission for step-therapy exceptions.
- 4. External review via state DOI. Free, independent, binding. GLP-1 medical-necessity appeals win 40-50% at external review per 2024-2025 KFF data. Deadline: 4 months from final internal denial.
Aetna plans vary — self-funded employer plans (ERISA) can override these standard criteria. Verify your specific plan via the number on the back of your Aetna card. Not medical or benefits advice.
If Aetna keeps denying — the cash paths
- LillyDirect Zepbound self-pay: $349-499/month via Lilly's direct-to-patient program. Vial format at $349, pen at $499.
- Compounded 503A tirzepatide (limited): legally narrow in 2026 after Lilly's enforcement wins; some compounding pharmacies still ship for verified shortage indications.
- Alternative on-label GLP-1: Wegovy self-pay at $499/month through Novo Nordisk direct.
Affiliate disclosure: Glpverdict earns commission on referrals via partner links. Editorial ranking is independent.
Frequently asked
Does Aetna cover Zepbound in 2026?
Yes on most commercial Aetna plans, but with a stricter path than UnitedHealthcare. Zepbound is a Tier 3 weight-management drug on the CVS Caremark formulary Aetna uses. Prior authorization is required AND step therapy typically requires you to have tried Wegovy (or documented an intolerance/contraindication) first.
What are Aetna's prior authorization criteria for Zepbound?
Standard 2026 criteria: (1) BMI ≥30 alone, or BMI ≥27 with at least one weight-related comorbidity (T2D, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease); (2) documented 6-month lifestyle-intervention attempt — Aetna enforces this more consistently than other major payers; (3) step therapy — must have tried Wegovy 4-6 months without meaningful weight loss OR documented intolerance; (4) contraindication attestation from prescriber.
How much does Zepbound cost with Aetna?
With PA + step therapy approved: commercial copay $30-90/month depending on plan tier. Layer the Lilly Zepbound Savings Card ($25/month for commercially insured) and out-of-pocket drops to $25/month for up to 13 fills. Without coverage: Lilly negotiated cash rate ~$550/month vs the $1,059 list price.
What if Aetna denies my Zepbound prior auth?
Read the denial letter — if it's step-therapy failure, submit Wegovy trial documentation (visit notes, weight logs, dose escalation) or the intolerance letter. If it's BMI documentation, get a fresh height/weight in your prescriber's chart. First appeal within 60 days, peer-to-peer review has higher success on step-therapy exceptions than paper appeals.
Does Aetna Medicare Advantage cover Zepbound?
For weight loss alone: no — Medicare Part D excludes weight-loss drugs by statute. For sleep apnea (Zepbound gained an FDA indication for moderate-severe OSA in obese adults in December 2024): coverage is opening up under some Aetna MA plans as the OSA indication takes hold. Check your specific plan.
How do I document a Wegovy failure or intolerance for Aetna step therapy?
Your prescriber submits: (1) start and stop dates of Wegovy attempt, (2) doses tried and duration at each, (3) weight measurements before/during/after, (4) specific reason for stopping (insufficient response after 4-6 months at maintenance dose, or specific adverse events like refractory nausea, pancreatitis, gallbladder disease). Chart notes matter — Aetna often audits these.
Can I skip Aetna's step therapy?
Yes with a "step-therapy exception request" — your prescriber attests that starting with Wegovy would be medically inappropriate (e.g., you have a contraindication to semaglutide, or a documented allergy). Aetna must respond within 72 hours for standard requests, 24 hours for urgent.
Last verified July 11, 2026. Formulary + step therapy change quarterly — check the CVS Caremark PDL for current status.